Enterobacteriaceae infection- Diagnosis, antibiotic resistance and prevention;Zakazenia pałeczkami jelitowymi- Diagnostyka, oporność na antybiotyki i profilaktyka

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 65, Issue , 2011, Pages 55-72

  Jarza̧b, Anna ^a   Górska Fra̧czek, Sabina ^a   Rybka, Jacek ^a   Witkowska, Danuta ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Antibiotic resistance; Enterobacteriaceae; Immunity; Intestinal infection; OMP; Shigella; Vaccine

Indexed keywords

ACTIVE IMMUNIZATION; ANTIBIOTIC RESISTANCE; ARTICLE; ENTEROBACTERIACEAE INFECTION; HUMAN; PATHOPHYSIOLOGY;

DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE INFECTIONS; HUMANS; IMMUNOTHERAPY, ACTIVE;

EID: 79958790219     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.933273     Document Type: Review

References (154)

1. Allison G.E., Verma N.K.: Serotype-converting bacteriophages and O-antigen modification in Shigella flexneri. Trends Microbiol., 2000; 8: 17-23. (Pubitemid 30066379)
2. Ashkenazi S., Passwell J.H., Harlev E., Miron D., Dagan R., Farzan N., Ramon R., Majadly F., Bryla D.A., Karpas A.B., Robbins J.B., Schneerson R.: Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children. J. Infect. Dis., 1999; 179: 1565-1568. (Pubitemid 29246612)
3. Aslanzadeh J.: Biochemical profile-based microbial identification systems. W: Advanced Techniques in Diagnostic Microbiology, t. 1, red.: Tang Y.W., Stratton C. W. Springer, Nashville, 2006; 84-116.
4. Badge R.M., Brookfield J.F.: The role of host factors in the population dynamics of selfish transposable elements. Theor. Biol., 1997; 187: 261-271. (Pubitemid 27359373)
5. Barquet N., Domingo P.: Smallpox: the triumph over the most terrible of the ministers of death. Ann. Intern. Med., 1997; 127: 635-642. (Pubitemid 127747201)
6. Biet F., Locht C., Kremer L.: Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens. J. Mol. Med., 2002; 80: 147-162. (Pubitemid 34230635)
7. Bischoff K.M., White D.G., McDermott P.F., Zhao S., Gaines S., Maurer J.J., Nisbet D.J.: Characterization of chloramphenicol resistance in beta-hemolytic Escherichia coli associated with diarrhea in neonatal swine. J. Clin. Microbiol., 2002; 40: 389-394. (Pubitemid 34130858)
8. Boyd E.F., Davis B.M., Hochhut B.: Bacteriophage-bacteriophage interactions in the evolution of pathogenic bacteria. Trends Microbiol., 2001; 9: 137-144. (Pubitemid 32182352)
9. Chakrabarti M.K., Bhattacharya J., Bhattacharya M.K., Nair G.B., Bhattacharya S.K., Mahalanabis D.: Killed oral Shigella vaccine made from Shigella flexneri 2a protects against challenge in the rabbit model of shigellosis. Acta Paediatr., 1999; 88: 161-165. (Pubitemid 29124318)
10. Cheng A.C., McDonald J.R., Thielman N.M.: Infectious diarrhea in developed and developing countries. J. Clin. Gastroenterol., 2005; 39: 757-773. (Pubitemid 41361892)
11. Clemens J.D., Stanton B., Stoll B., Shahid N.S., Banu H., Chowdhury A.K.: Breastfeeding as a determinant of severity in shigellosis: evidence for protection throughout the first three years of life in Bangladeshi children. Am. J. Epidemiol., 1986; 123: 710-720. (Pubitemid 16104108)
12. Cohen D., Ashkenazi S., Green M.S., Gdalevich M., Robin G., Slepon R., Yavzori M., Orr N., Block C., Ashkenazi I., Shemer J., Taylor D.N., Hale T.L., Sadoff J.C., Pavliakova D., Schneerson R., Robbins J.B.: Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults. Lancet, 1997; 18: 155-159. (Pubitemid 27039194)
13. Cohen D., Block C., Green M.S., Lowell G.H., Ofek I.: Immunoglobulin M, A and G antibody response to lipopolysaccharide O antigen in symptomatic and asymptomatic Shigella infections. J. Clin. Microbiol., 1989; 27: 162-167. (Pubitemid 19021964)
14. Coster T.S., Hoge C.W., VanDeVerg L.L., Hartman A.B., Oaks E.V., Venkatesan M.M., Cohen D., Robin G., Fontaine-Thompson A., Sansonetti P.J., Hale T.L.: Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602. Infect. Immun., 1999; 67: 3437-3443. (Pubitemid 29291514)
15. Cryz S.J. Jr, Mortimer P., Cross A.S., Fürer E., Germanier R.: Safety and immunogenicity of a polyvalent Klebsiella capsular polysaccharide vaccine in humans. Vaccine, 1986; 4: 15-20. (Pubitemid 16129408)
16. Cummings J.H., Macfarlane G.T.: The control and consequences of bacterial fermentation in the human colon. J. Appl. Bacteriol., 1991; 70: 443-459.
17. Czarny A., Witkowska D., Mulczyk M.: Phagocytic and bactericidal properties of macrophages of mice immunized with outer membrane proteins (OMP) of Shigella. Arch. Immunol. Ther. Exp., 1988; 36: 701-709.
18. Czarny A., Witkowska D., Mulczyk M.: Induction of tumor necrosis factor and interleukin 6 by outer membrane proteins of Shigella in spleen cells and macrophages of mice. Arch. Immunol. Ther. Exp., 1993; 41: 153-157. (Pubitemid 23331578)
19. Czarny A., Witkowska D., Mulczyk M.: Effect of outer membrane proteins (OMP) of Shigella on interleukin 2 (IL-2) production by spleen cells of mice. Arch. Immunol. Ther. Exp., 1994; 42: 159-161.
20. Dare D.: Rapid bacterial characterization and identification by MALDI-TOF mass spectrometry. W: Advanced Techniques in Diagnostic Microbiology, t. 1, red.: Tang Y.W., Stratton C. W. Springer, Nashville, 2006; 117-133.
21. Dart R.K.: Microbiology for the Analytical Chemist. The Royal Society of Chemistry, Cambridge, UK, 1996.
22. Duménil D., Olivo J.C., Pellegrini S., Fellous M., Sansonetti P.J., Tran Van Nhieu G.: Interferon a inhibits a Src-mediated pathway necessary for Shigella-induced cytoskeletal rearrangements in epithelial cells. J. Cell Biol., 1998; 143: 1003-1012. (Pubitemid 28547399)
23. Dunne E.F., Fey P.D., Kludt P., Reporter R., Mostashari F., Shillam P., Wicklund J., Miller C., Holland B., Stamey K., Barrett T.J., Rasheed J.K., Tenover F.C., Ribot E.M., Angulo F.J.: Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC beta-lactamase. JAMA, 2000; 284: 3151-3156. (Pubitemid 32039078)
24. DuPont H.L., Hornick R.B., Snyder M.J., Libonati J.P., Formal S.B., Gangarosa E.J.: Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection. J. Infect. Dis., 1972; 125: 12-16.
25. Ericsson C.D.: Travellers' diarrhoea. Int. J. Antimicrob. Agents, 2003; 21: 116-124. (Pubitemid 36298569)
26. Espina M., Olive A.J., Kenjale R., Moore D.S., Ausar S.F., Kaminski R.W., Oaks E.V., Middaugh C.R., Picking W.D., Picking W.L.: IpaD localizes to the tip of the Type III Secretion System needle of Shigella flexneri. Infect. Immun., 2006; 74: 4391-4400. (Pubitemid 44157224)
27. Evans D.G, Graham D.Y, Evans D.J Jr.: Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers. Response to challenge with virulent enterotoxigenic Escherichia coli. Gastroenterology, 1984; 87: 934-940. (Pubitemid 14040469)
28. Fennelly G.J., Khan S.A., Abadi M.A., Wild T.F., Bloom B.R.: Mucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector. J. Immunol., 1999; 162: 1603-1610. (Pubitemid 29307035)
29. Ferreccio C., Prado V., Ojeda A., Cayyazo M., Abrego P., Guers L., Levine M.M.: Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile. Am. J. Epidemiol., 1991; 134: 614-627.
30. Finney M., Smullen J., Foster H.A., Brokx S., Storey D.M.: Evaluation of Chromocult coliform agar for the detection and enumeration of Enterobacteriaceae from faecal samples from healthy subjects. J. Microbiol. Meth., 2003; 54: 353-358. (Pubitemid 36773977)
31. Formal S.B., Oaks E.V., Olsen R.E., Wingfield-Eggleston M., Snoy P.J., Cogan J.P: Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei. J. Infect. Dis., 1991; 164: 533-537.
32. Gamian A, Witkowska D., Mieszala M., Staniszewska M., Przondo-Mordarska A.: Fimbriae as a Cartier for antibacterial vaccines. Nova Acta Leopoldina, 1999; 80: 265-272.
33. Girard M.P., Steele D., Chaignat C.L., Kieny M.P.: A review of vaccine research and development: human enteric infections. Vaccine, 2006; 24: 2732-2750.
34. Girón J.A.: Expression of flagella and motility by Shigella. Mol. Microbiol., 1995; 18: 63-75.
35. Gomez H.F., Ochoa T.J., Carlin L.G., Cleary T.G.: Human lactoferrin impairs virulence of Shigella flexneri. J. Infect. Dis., 2003; 187: 87-95. (Pubitemid 36034475)
36. Gómez-Duarte O.G., Bai J., Newell E.: Detection of Escherichia coli, Salmonella spp., Shigella spp., Yersinia enterocolitica, Vibrio cholerae, and Campylobacter spp. enteropathogens by 3-reaction multiplex polymerase chain reaction. Diagn. Microbiol. Infect. Dis., 2009; 63: 1-9.
37. Goñi-Urriza M., Capdepuy M., Arpin C., Raymond N., Caumette P., Quentin C.: Impact of an urban effluent on antibiotic resistance of riverine Enterobacteriaceae and Aeromonas spp. Appl. Environ. Microbiol., 2000; 66: 125-132. (Pubitemid 30030506)
38. Górska S., Jarza̧b A, Gamian A.: Bakterie probiotyczne w przewodzie pokarmowym człowieka jako czynnik stymuluja̧cy układ odpornościowy. Postȩpy Hig. Med. Dośw., 2009; 63: 653-667.
39. Guerrant R.L., Kosek M., Moore S., Lorentz B., Brantley R., Lima A.A.: Magnitude and impact of diarrheal diseases. Arch. Med. Res., 2002; 33: 351-355. (Pubitemid 35299555)
40. Guichon A., Hersh D., Smith M.R., Zychlinsky A.: Structure-function analysis of the Shigella virulence factor IpaB. J. Bacteriol., 2001; 183: 1269-1276. (Pubitemid 32107722)
41. Guttman J.A., Finlay B.B.: Subcellular alterations that lead to diarrhea during bacterial pathogenesis. Trends Microbiol., 2008; 16: 535-542.
42. Haas M.J., Dowding J.E.: Aminoglycoside-modifying enzymes. Methods Enzymol., 1975; 43: 611-628.
43. Hale Boothe D.D., Smith M.C., Gattie D.K., Das K.C.: Characterization of microbial populations in landfill leachate and bulk samples during aerobic bioreduction. Adv. Environ. Res., 2001; 5: 285-294. (Pubitemid 33585833)
44. Han J.: Molecular differential diagnoses of infectious diseases: is the future now? W: Advanced Techniques in Diagnostic Microbiology, t. 1, red.: Tang Y.W., Stratton C. W. Springer, Nashville, 2006; 472-504.
45. Hardegen C., Messler S., Henrich B., Pfeffer K., Würthner J., MacKenzie C.R.: A set of novel multiplex Taqman real-time PCRs for the detection of diarrhoeagenic Escherichia coli and its use in determining the prevalence of EPEC and EAEC in a university hospital. Ann. Clin. Microbiol. Antimicrob., 2010; 9: 5.
46. Hathaway L.J., Griffin G.E., Sansonetti P.J., Edgeworth J.D.: Human monocytes kill Shigella flexneri but then die by apoptosis associated with suppression of proinflammatory cytokine production. Infect. Immun., 2002; 70: 3833-3842. (Pubitemid 34666024)
47. Hayward R.D., Cain R.J., McGhie E.J., Phillips N., Garner M.J., Koronakis V.: Cholesterol binding by the bacterial type III translocon is essential for virulence effector delivery into mammalian cells. Mol. Microbiol., 2005; 56: 590-603. (Pubitemid 40562355)
48. Hodgkinson J.L., Horsley A., Stabat D., Simon M., Johnson S., da Fonseca P.C., Morris E.P., Wall J.S., Lea S.M., Blocker A.J.: Three-dimensional reconstruction of the Shigella T3SS transmembrane re-gions reveals 12-fold symmetry and novel features throughout. Nat. Struct. Mol. Biol., 2009; 16: 477-485.
49. Hong Y., Liu T., Lee M.D., Hofacre C.L., Maier M., White D.G., Ayers S., Wang L., Berghaus R., Maurer J.J.: Rapid screening of Salmonella enterica serovars Enteritidis, Hadar, Heidelberg and Typhimurium using a serologically-correlative allelotyping PCR targeting the O and H antigen alleles. BMC Microbiol., 2008; 8: 178.
50. Huilan S., Zhen L.G., Mathan M.M., Mathew M.M., Olarte J., Espejo R., Khin Maung U., Ghafoor M.A., Khan M.A., Sami Z., Sutton R.G.: Etiology of acute diarrhoea among children in developing countries: a multicentre study in five countries. Bull. World Health Organ., 1991; 69: 549-555.
51. Iijima H., Takahashi I., Kiyono H.: Mucosal immune network in the gut for the control of infectious diseases. Rev. Med. Virol., 2001; 11: 117-133. (Pubitemid 32267782)
52. Ishii Y., Kimura S., Alba J., Shiroto K., Otsuka M., Hashizume N., Tamura K., Yamaguchi K.: Extended-spectrum beta-lactamase-producing Shiga toxin gene (Stx1)-positive Escherichia coli O26:H11: a new concern. J. Clin. Microbiol., 2005; 43: 1072-1075. (Pubitemid 40364920)
53. Islam D., Christensson B.: Disease dependent changes in T-cell populations in patients with shigellosis. APMIS, 2000; 108: 251-260. (Pubitemid 30304051)
54. Islam D., Veress B., Bardhan P.K., Lindberg A.A., Christensson B.: Quantitative assessment of IgG and IgA subclass producing cells in rectal mucosa during shigellosis. J. Clin. Pathol., 1997; 50: 513-520. (Pubitemid 27316002)
55. Jacoby G.A., Medeiros A.A.: More extended-spectrum beta-lactamases. Antimicrob. Agents Chemother., 1991; 35: 1697-1704.
56. Jarlier V., Nicolas M.H., Fournier G., Philippon A.: Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis., 1988; 10: 867-878.
57. Kawai K., Liu Y., Ohnishi K., Oshima S.: A conserved 37 kDa outer membrane protein of Edwardsiella tarda is an effective vaccine candidate. Vaccine, 2004; 22: 3411-3418. (Pubitemid 39078759)
58. Kim S., Kim J., Kang Y., Park Y., Lee B.: Occurrence of extended spectrum beta-lactamases in members of the genus Shigella in the Republic of Korea. J. Clin. Microbiol., 2004; 42: 5264-5269. (Pubitemid 39506239)
59. Klee S.R., Tzschaschel B.D., Singh M., Fält I., Lindberg A.A., Timmis K.N., Guzmán C.A.: Construction and characterization of genetically-marked bivalent anti-Shigella dysenteriae 1 and anti-Shigella flexneri Y live vaccine candidates. Microb. Pathog., 1997; 22: 363-376. (Pubitemid 27230912)
60. Kobayashi N., Nishino K., Yamaguchi A.: Novel macrolide-specific ABC-type efflux transporter in Escherichia coli. J. Bacteriol., 2001; 183: 5639-5644. (Pubitemid 32898610)
61. Kohler H., Rodrigues S.P., McCormick B.A.: S. flexneri interactions with the basolateral membrane domain of polarized model intestinal epithelium: role of LPS in cell invasion and in activation of the mitogen activated protein kinase ERK. Infect. Immun., 2002; 70: 1150-1158. (Pubitemid 34163386)
62. Kotloff K.L., Herrington D.A., Hale T.L., Newland J.W., Van De Verg L., Cogan J.P., Snoy P.J., Sadoff J.C., Formal S.B., Levine M.M..: Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen. Infect. Immun., 1992; 60: 2218-2224.
63. Kotloff K.L., Noriega F., Losonsky G.A., Sztein M.B., Wasserman S.S., Nataro J.P., Levine M.M.: Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG. Infect. Immun., 1996; 64: 4542-4548. (Pubitemid 26357056)
64. Kramer T.T., Roof M.B., Matheson R.R.: Safety and efficacy of an attenuated strain Salmonella choleraesuis for vaccination of swine. Am. J.Vet. Res., 1992, 53: 444-448.
65. Kruger T., Szabo D., Keddy K.H., Deeley K., Marsh J.W., Hujer A.M., Bonomo R.A., Paterson D.L.: Infections with nontyphoidal Salmonella species producing TEM-63 or a novel TEM enzyme, TEM-131, in South Africa. Antimicrob. Agents Chemother., 2004; 48: 4263-4270. (Pubitemid 39434885)
66. Kubler-Kielb J., Vinogradov E., Mocca C., Pozsgay V., Coxon B., Robbins J.B., Schneerson R.: Immunochemical studies of Shigella flexneri 2a and 6, and Shigella dysenteriae type 1 O-specific polysaccharide-core fragments and their protein conjugates as vaccine candidates. Carbohydr. Res., 2010; 345: 1600-1608.
67. Laupland K.B., Schonheyder H.C., Kennedy K.J., Lyytikainen O., Valiquette L., Galbraith J., Collignon P., International Bacteremia Surveillance Collaborative.: Salmonella enterica bacteraemia: A multi-national population-based cohort study. BMC Infect. Dis., 2010; 10: 95-100.
68. Levine M.M., Kaper J.B., Black R.E., Clements M.L.: New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiol. Rev., 1983; 47: 510-550. (Pubitemid 14210910)
69. Lindell S.S., Quinn P.: Use of bile-esculin agar for rapid differentiation of Enterobacteriaceae. J. Clin. Microbiol., 1975; 1: 440-443.
70. Lipps G.: Plasmids: Current Research and Future Trends. Caister Academic Press. 2008, University of Bayreuth, Germany, 2008.
71. Livermore D.M., Brown D.F.: Detection of beta-lactamase-mediated resistance. J. Antimicrob. Chemother., 2001; 48: 59-64.
72. Lombard M., Pastoret P.P., Moulin A.M.: A brief history of vaccines and vaccination. Rev. Sci. Tech., 2007; 26: 29-48. (Pubitemid 47148811)
73. López-Gigosos R., García-Fortea P., Reina-Doña E., Plaza-Martín E.: Effectiveness in prevention of travellers' diarrhoea by an oral cholera vaccine WC/rBS. Travel Med. Infect. Dis., 2007; 5: 380-384. (Pubitemid 350011950)
74. Louie M., Louie L., Simor A.E.: The role of DNA amplification technology in the diagnosis of infectious diseases. CMAJ, 2000; 163: 301-309. (Pubitemid 30670676)
75. Lowell G.H., Kaminski R.W., Grate S., Hunt R.E., Charney C, Zimmer S., Colleton C.: Intranasal and intramuscular proteosome-staphylococcal enterotoxin B (SEB) toxoid vaccines: immunogenicity and efficacy against lethal SEB intoxication in mice. Infect. Immun., 1996; 64: 1706-1713. (Pubitemid 26130622)
76. Lumsden J.S., Wilkie B.N., Clarke R.C.: Resistance to fecal shedding in pigs and chickens vaccinated with an aromatic depend mutant of Salmonella typhimurium. Am. J. Vet. Res., 1991, 52: 1784-1787.
77. Mac Aogáin M., Mooij M.J., Adams C., Clair J., O'Gara F.: Emergence of extended-spectrum beta-lactamase and fluoroquinolone resistance genes among Irish multidrug-resistant isolates. Diagn. Microbiol. Infect. Dis., 2010; 67:106-109.
78. Mackay I. M.: Real-Time PCR in Microbiology. From Diagnosis to Characterization. Caister Academic Press, Norfolk, UK, 2007.
79. Macmillan H., Norimine J., Brayton K.A., Palmer G.H., Brown W.C.: Physical linkage of naturally complexed bacterial outer membrane proteins enhances immunogenicity. Infect. Immun., 2008; 76: 1223-1229. (Pubitemid 351428085)
80. Mandic-Mulec I., Weiss J., Zychlinsky A.: Shigella flexneri is trapped in polymorphonuclear leukocyte vacuoles and efficiently killed. Infect. Immun., 1997; 65: 110-115. (Pubitemid 27008910)
81. Mandine E., Salles M.F., Zalisz R., Guenounou M., Smets P.: Murine monoclonal antibodies to Klebsiella pneumoniae protect against lethal endotoxemia and experimental infection with capsulated K. pneumoniae. Infect. Immun., 1990; 58: 2828-2833. (Pubitemid 20267667)
82. Marlovits T.C., Kubori T., Sukhan D.R., Thomas D.R., Galán J.E., Unger V.M.: Structural insights into the assembly of the type III secretion needle complex. Science, 2004; 306: 1040-1042. (Pubitemid 39482908)
83. Meitert T., Pencu E., Ciudin L., Tonciu M.: Vaccine strain Sh. flexneri T32-Istrati. Studies in animals and in volunteers. Antidysentery immunoprophylaxis and immunotherapy by live vaccine Vadizen (Sh. flexneri T32-Istrati). Arch. Roum. Pathol. Exp. Microbiol., 1984; 43: 251-278. (Pubitemid 15086377)
84. Mel D.M., Arsic B.L., Nikolic B.D., Radovanic M.L.: Studies on vaccination against bacillary dysentery. 4. Oral immunization with live monotypic and combined vaccines. Bull. World Health Organ., 1968; 39: 375-380.
85. Mukhopadhaya A., Mahalanabis D., Khanam J., Chakrabarti M.K.: Protective efficacy of oral immunization with heat-killed Shigella flexneri 2a in animal model: study of cross protection, immune response and antigenic recognition. Vaccine, 2003; 21: 3043-3050. (Pubitemid 36703212)
86. Mulczyk M., Adamus G., Witkowska D., Romanowska E.: Studies on virulence of Shigella flexneri. Protective effect of outer membrane proteins. Arch. Immunol. Ther. Exp., 1981; 29: 85-90. (Pubitemid 12225336)
87. Munday C.J., Whitehead G.M., Todd N.J., Campbell M., Hawkey P.M.: Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum beta-lactamases in York, UK. J. Antimicrob. Chemother., 2004; 54: 628-633. (Pubitemid 39263904)
88. Nataro J.P., Mai V., Johnson J., Blackwelder W.C., Heimer R., Tirrell S., Edberg S.C., Braden C.R., Glenn Morris J. Jr, Hirshon J.M.: Diarrheagenic Escherichia coli infection in Baltimore, Maryland, New Haven, Connecticut. Clin. Infect. Dis., 2006; 43: 402-407.
89. Nato F, Phalipon A, Nguyen TL, Diep TT, Sansonetti P, Germani Y.: Dipstick for rapid diagnosis of Shigella flexneri 2a in stool. PLoS One, 2007; 2: e361.
90. Nikaido H.: Bacterial resistance to antibiotics as a function of outer membrane permeability. J. Antimicrob. Chemother., 1988; 22, Suppl. A: 17-22.
91. Noriega F.R., Liao F.M., Maneval D.R., Ren S., Formal S.B., Levine M.M.: Strategy for cross-protection among Shigella flexneri serotypes. Infect. Immun., 1999; 67: 782-788. (Pubitemid 29059218)
92. Noriega F.R., Losonsky G., Wang J.Y., Formal S.B., Levine M.M.: Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli. Infect. Immun., 1996; 64: 23-27.
93. Noriega F.R., Wang J.Y., Losonsky G., Maneval D.L., Hone D.M., Levine M.M.: Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine. Infect. Immun., 1994; 62: 5168-5172. (Pubitemid 24332831)
94. Oberhelman R.A., Kopecko D.J., Salazar-Lindo E., Gotuzzo E., Buysse J.M., Venkatesan M.M., Fernandez-Prada C., Guzman M., Leon-Barua R., Sack R.B.: Prospective study of systemic and mucosal immune responses in dysenteric patients to specific Shigella invasion plasmid antigens and lipopolysaccharides. Infect. Immun., 1991; 59: 2341-2350.
95. O'Hara C.M.: Manual and automated instrumentation for identification of Enterobacteriaceae and other aerobic Gram-negative bacilli. Clin. Microbiol. Rev., 2005; 18: 147-162. (Pubitemid 40170666)
96. Passwell J.H., Harlev E., Ashkenazi S., Chu C., Miron D., Ramon R., Farzan N., Shiloach J., Bryla D.A., Majadly F., Roberson R., Robbins J.B., Schneerson R.: Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel. Infect. Immun., 2001; 69: 1351-1357. (Pubitemid 32187580)
97. Paterson D.L.: Resistance in gram-negative bacteria: Enterobacteriaceae. Am. J. Med., 2006; 119: S20-S28.
98. Paterson D.L., Hujer K.M., Hujer A.M., Yeiser B., Bonomo M.D., Rice L.B., Bonomo R.A.; International Klebsiella Study Group.: Extended-spectrum b-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type b-lactamases. Antimicrob. Agents Chemother., 2003; 47: 3554-3560. (Pubitemid 37345719)
99. Paterson D.L., Ko W.C., Von Gottberg A., Mohapatra S., Casellas J.M., Goossens H., Mulazimoglu L., Trenholme G., Klugman K.P., Bonomo R.A., Rice L.B., Wagener M.M., McCormack J.G., Yu V.L.: International prospective study of Klebsiella pneumonia bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial infections. Ann. Intern. Med., 2004; 140: 26-32. (Pubitemid 38055918)
100. Pendaries C., Tronchère H., Arbibe L., Mounier J., Gozani O., Cantley L., Fry M.J., Gaits- Iacovoni F., Sansonetti P.J., Payrastre B.: PtdIns(5)P activates the host cell PI3-kinase/akt pathway during Shigella flexneri infection. EMBO J., 2006; 25: 1024-1034. (Pubitemid 43372116)
101. Petroni A., Corso A., Melano R., Cacace M.L., Bru A.M., Rossi A., Galas M.: Plasmidic extended-spectrum beta-lactamases in Vibrio cholerae O1 El Tor isolates in Argentina. Antimicrob. Agents Chemother., 2002; 46: 1462-1468. (Pubitemid 34415329)
102. Phalipon A., Cardona A., Kraehenbuhl J.P., Edelman L., Sansonetti P.J., Corthesy B.: Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo. Immunity, 2002; 17: 107-115. (Pubitemid 34874623)
103. Poole K.: Mechanisms of bacterial biocide and antibiotic resistance. J. Appl. Microbiol., 2002; 92: 55S-64S. (Pubitemid 34535506)
104. Ram P.K., Crump J.A., Gupta S.K., Miller M.A., Mintz E.D.: Part II. Analysis of data gaps pertaining to Shigella infections in low and medium human development index countries, 1984-2005. Epidemiol. Infect., 2008; 136: 577-603. (Pubitemid 351472169)
105. Ramarao N., Le Clainche C., Izard T., Bourdet-Sicard R., Ageron E., Sansonetti P.J., Carlier M., Van Nhieu G.T.: Capping host actin filaments by vinculin activated by the Shigella IpaA carboxyl-terminal domain. FEBS Lett., 2007, 581: 853-857. (Pubitemid 46282716)
106. Raqib R., Lindberg A.A., Wretlind B., Bardhan P.K., Andersson U., Andersson J.: Persistence of local cytokine production in shigellosis in acute and convalescent stages. Infect. Immun., 1995; 63: 289-296.
107. Reier-Nilsen T., Farstad T., Nakstad B., Lauvrak V., Steinbakk M.: Comparison of broad range 16S rDNA PCR and conventional blood culture for diagnosis of sepsis in the newborn: a case control study. BMC Pediatr., 2009; 9: 5.
108. Reis R.S., Horn F.: Enteropathogenic Escherichia coli, Samonella, Shigella and Yersinia: cellular aspects of host-bacteria interactions in enteric diseases. Gut Pathog., 2010; 2: 8.
109. Robin G., Keisari Y., Slepon R., Ashkenazi S., Cohen D.: Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines. Vaccine, 1999; 17: 3109-3115. (Pubitemid 29366992)
110. Rohde J.R., Breitkreutz A., Chenal A., Sansonetti P.J., Parsot C.: Type III secretion effectors of the IpaH family are E3 ubiquitin ligases. Cell Host Microbe., 2007; 1: 77-83. (Pubitemid 46506011)
111. Roy S., Das A.B., Ghosh A.N., Biswas T.: Purification, pore-forming ability, and antigenic relatedness of the major outer membrane protein of Shigella dysenteriae type 1. Infect. Immun., 1994; 62: 4333-4338. (Pubitemid 24301960)
112. Rui X., Xu Y., Wan H., Su G., Huang C.: Construction of a stable and non-resistant bivalent vaccine candidate strain against Shigella flexneri 2a and Shigella sonnei. Chin. J. Biotechnol., 1996; 12: 89-97.
113. Ruiz J.: Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J. Antimicrob. Chemother., 2003; 51: 1109-1117. (Pubitemid 36622067)
114. Ruiz N., Kahne D., Silhavy T.J.: Advances in understanding bacterial outer-membrane biogenesis. Nat. Rev. Microbiol., 2006; 4: 57-66. (Pubitemid 43135287)
115. Salminen S., Isolauri E., Onnela T.: Gut flora in normal and disordered states. Chemotherapy. 1995; 41(Suppl.1): 5-15.
116. Sansonetti P.J., Arondel J., Huerre M., Harada A., Matsushima K.: Interleukin-8 controls bacterial transepithelial translocation at the cost of epithelial destruction in experimental shigellosis. Infect. Immun., 1999; 67: 1471-1480. (Pubitemid 29108531)
117. Sansonetti P., Phalipon A.: Shigellosis: from molecular pathogenesis of infection to protective immunity and vaccine development. Res. Immunol., 1996; 147: 595-602.
118. Schroeder G.N., Hilbi H.: Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. Clin. Microbiol. Rev., 2008; 21: 134-156. (Pubitemid 351160013)
119. Silva J.: Mechanisms of antibiotic resistance. Curr. Ther. Res., 1996; 57: 30-35.
120. Singer M., Sansonetti P.J.: IL-8 is a key chemokine regulating neutrophil recruitment in a new mouse model of Shigella-induced colitis. J. Immun., 2004, 173: 4197-4206. (Pubitemid 39280786)
121. Skoudy A., Nhieu G.T., Mantis N., Arpin M., Mounier J., Gounon P., Sansonetti P.J.: A functional role for ezrin during Shigella flexneri entry into epithelial cells. J. Cell. Sci., 1999; 112: 2059-2068. (Pubitemid 29355421)
122. Staniszewska M., Witkowska D., Gamian A.: Fimbrie jako czynnik patogenności bakterii i nośnik w szczepionkach koniugatowych. Postȩpy Hig. Med. Dośw., 2000; 54: 727-747.
123. Suzuki T., Franchi L., Toma C., Ashida H., Ogawa M., Yoshikawa Y., Mimuro H., Inohara N., Sasakawa C., Nuñez G.: Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella infected macrophages. PLoS Pathog., 2007; 3: e111.
124. Taylor D.N., Trofa A.C., Sadoff J., Chu C., Bryla D., Shiloach J., Cohen D., Ashkenazi S., Lerman Y., Egan W., Schneerson R., Robbins J.B.: Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids. Infect. Immun., 1993; 61: 3678-3687. (Pubitemid 23260037)
125. Tommassen J.: Assembly of outer-membrane proteins in bacteria and mitochondria. Microbiology, 2010; 156: 2587-2596.
126. Tran Van Nhieu G., Caron E., Hall A., Sansonetti P.J.: IpaC induces actin polymerization and filopodia formation during Shigella entry into epithelial cells. EMBO J., 1999; 18: 3249-3262. (Pubitemid 29276572)
127. Tribble D., Kaminski R., Cantrell J., Nelson M., Porter C., Baqar S., Williams C., Arora R., Saunders J., Ananthakrishnan M., Sanders J., Zaucha G., Turbyfill R., Oaks E.: Safety and immunogenicity of a Shigella flexneri 2a Invaplex 50 intranasal vaccine in adult volunteers. Vaccine, 2010; 28: 6076-6085.
128. Turbyfill K.R., Hartman A.B., Oaks E.V.: Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine. Infect. Immun., 2000; 68: 6624-6632. (Pubitemid 32463363)
129. Turbyfill K.R., Kaminski R.W., Oaks E.V.: Immunogenicity and efficacy of highly purified invasin complex vaccine from Shigella flexneri 2a. Vaccine, 2008; 26: 1353-1364.
130. Van Baar B.L.: Characterisation of bacteria by matrix-assisted laser desorption/ionisation and electrospray mass spectrometry. FEMS Microbiol. Rev., 2000; 24: 193-219. (Pubitemid 30136442)
131. Van De Verg L.L., Bendiuk N.O., Kotloff K., Marsh M.M., Ruckert J.L., Puryear J.L., Taylor D.N., Hartman A.B.: Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infection. Vaccine, 1996; 14: 1062-1068. (Pubitemid 26281295)
132. Van De Verg L.L., Mallett C.P., Collins H.H., Larsen T., Hammack C., Hale T.L.: Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri serotype 2a infection. Infect. Immun., 1995; 63: 1947-1954.
133. Vecino W.H., Morin P.M., Agha R., Jacobs W.R. Jr, Fennelly G.J.: Mucosal DNA vaccination with highly attenuated Shigella is superior to attenuated Salmonella and comparable to intramuscular DNA vaccination for T cells against HIV. Immunol. Lett., 2002; 82: 197-204. (Pubitemid 34556965)
134. Vecino W.H., Quanquin N.M., Martinez-Sobrido L., Fernandez-Sesma A., García-Sastre A., Jacobs W.R. Jr, Fennelly G.J.: Mucosal immunization with attenuated Shigella flexneri harboring an influenza hemagglutinin DNA vaccine protects mice against a lethal influenza challenge. Virology, 2004; 325: 192-199. (Pubitemid 38902785)
135. Von Seidlein L., Kim D.R., Ali M., Lee H., Wang X., Thiem V.D., Canh do G., Chaicumpa W., Agtini M.D., Hossain A., Bhutta Z.A., Mason C., Sethabutr O., Talukder K., Nair G.B., Deen J.L., Kotloff K., Clemens J.: A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Med., 2006; 3: e353.
136. Watanabe T.: Infective heredity of multiple drug resistance in bacteria. Bacteriol. Rev., 1963; 27: 87-115.
137. Way S.S., Borczuk A.C., Dominitz R., Goldberg M.B.: An essential role for gamma interferon in innate resistance to Shigella flexneri infection. Infect. Immun., 1998; 66: 1342-1348. (Pubitemid 128471488)
138. Way S.S., Borczuk A.C., Goldberg M.B.: Adaptive immune response to Shigella flexneri 2a cydC in immunocompetent mice and mice lacking immunoglobulin A. Infect. Immun., 1999; 67: 2001-2004. (Pubitemid 29144427)
139. Way S.S., Borczuk A.C., Goldberg M.B.: Thymic independance of adaptive immunity to the intracellular patogen Shigella flexneri serotype 2a. Infect. Immun., 1999; 67: 3970-3979. (Pubitemid 29357017)
140. Weinrauch Y., Drujan D., Shapiro S.D., Weiss J., Zychlinsky A.: Neutrophil elastase targets virulence factors of enterobacteria. Nature, 2002; 417: 91-94. (Pubitemid 34498822)
141. Wiegand I., Geiss H.K., Mack D., Stürenburg E., Seifert H.: Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use
142. Williamson R.: Resistance of Clostridium perfringens to beta-lactam antibiotics mediated by a decreased affinity of a single essential penicillin-binding protein. J. Gen. Microbiol., 1983; 129: 2339-2342. (Pubitemid 13038920)
143. Witkowska D., Adamus G., Mulczyk M., Romanowska E.: Outer membrane protein composition of Shigella flexneri. FEMS Microbiol. Lett., 1982; 13: 109-111. (Pubitemid 12144185)
144. Witkowska D., Bartyś A., Gamian A.: Białka oslony komórkowej pa̧eczek jelitowych i ich udział w patogenności oraz odporności przeciwbakteryjnej. Postȩpy Hig. Med. Dośw. 2009; 63: 176-199.
145. Witkowska D., Czarny A., Mulczyk M.: Humoral response in mice immunized with outer membrane proteins of Shigella flexneri. Arch. Immunol. Ther. Exp., 1986; 34: 499-504.
146. Witkowska D., Maslowska E., Staniszewska M., Szostko B., Jankowski A., Gamian A.: Enterobacterial 38-kDa outer membrane protein is an age-dependent molecular marker of innate immunity and immunoglobulin deficiency as results from its reactivity with IgG and IgA antibody. FEMS Immunol. Med. Microbiol., 2006; 48: 205-214. (Pubitemid 44581584)
147. Witkowska D., Mieszala M., Gamian A., Staniszewska M., Czarny A., Przondo-Mordarska A., Jaquinod M., Forest E.: Major structural proteins of type 1 and type 3 Klebsiella fimbriae are effective protein carriers and immunogens in conjugates as revealed from their immunochemical characterization. FEMS Immunol. Med. Microbiol., 2005; 45: 221-230. (Pubitemid 41040005)
148. Witkowska D., Mleczko J., Mulczyk M.: Transfer of immunity by means of spleen cells from mice immunized with outer membrane proteins of Shigella flexneri. Arch. Immunol. Ther. Exp., 1985; 33: 629-635. (Pubitemid 16188753)
149. Wu F., Della-Latta P.: Pulsed-field gel electrophoresis. W: Advanced Techniques in Diagnostic Microbiology, t. 1, red.: Tang Y.W., Stratton C. W. Springer, Nashville 2006, 143-157.
150. Xiang Y., Han W.: Bacterial identification based on 16S ribosomal RNA gene sequence analysis. W: Advanced Techniques in Diagnostic Microbiology, t. 1, red.: Tang Y.W., Stratton C. W. Springer, Nashville, 2006; 323-332.
151. Yokochi T, Inoue Y, Kato Y, Sugiyama T, Jiang GZ, Kawai M, Fukada M, Takahashi K.: Strong adjuvant action of Klebsiella O3 lipopolysaccharide and its inhibition of systemic anaphylaxis. FEMS Immunol. Med. Microbiol., 1995; 10: 181-184.
152. Yoshida S., Handa Y., Suzuki T., Ogawa M., Suzuki M., Tamai A., Abe A., Katayama E., Sasakawa C.: Microtubule-severing activity of Shigella is pivotal for intercellular spreading. Science, 2006, 314: 985-989. (Pubitemid 44749942)
153. Zwillich S.H., Duby A.D., Lipsky P.E.: T-lymphocyte clones responsive to Shigella flexneri. J. Clin. Microbiol., 1989; 27: 417-421. (Pubitemid 19072346)
154. Zychlinsky A., Prevost M.C., Sansonetti P.J.: Shigella flexneri induces apoptosis in infected macrophages. Nature, 1992; 358: 167-169.